Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial

被引：0
|
作者：
Stephanie E Combs
Meinhard Kieser
Daniel Habermehl
Jürgen Weitz
Dirk Jäger
Piero Fossati
Roberto Orrechia
Rita Engenhart-Cabillic
Richard Pötter
Manjit Dosanjh
Oliver Jäkel
Markus W Büchler
Jürgen Debus
机构：
[1] University Hospital of Heidelberg,Deparment of Radiation Oncology
[2] University Hospital of Heidelberg,Department of Biostatistics
[3] University Hospital of Heidelberg,Department of Surgery
[4] Medizinische Onkologie,Nationales Centrum für Tumorerkrankungen (NCT)
[5] Fondazione CNAO - Centro Nazionale di Adroterapia Oncologica,Department of Radiation Oncology
[6] Baldingerstraße,Department of Radiation Oncology
[7] University Hospital of Marburg,undefined
[8] University of Vienna,undefined
[9] CERN,undefined
[10] Heidelberger Ionenstrahl Therapiezentrum (HIT),undefined
来源：
BMC Cancer | / 12卷
关键词：
Planning Target Volume; Adenoid Cystic Carcinoma; Relative Biological Effectiveness; Recurrent Rectal Cancer; Data Safety Monitoring Board;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
    Stephanie E Combs
    Iris Burkholder
    Lutz Edler
    Stefan Rieken
    Daniel Habermehl
    Oliver Jäkel
    Thomas Haberer
    Renate Haselmann
    Andreas Unterberg
    Wolfgang Wick
    Jürgen Debus
    BMC Cancer, 10
  • [22] Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
    Combs, Stephanie E.
    Burkholder, Iris
    Edler, Lutz
    Rieken, Stefan
    Habermehl, Daniel
    Jaekel, Oliver
    Haberer, Thomas
    Haselmann, Renate
    Unterberg, Andreas
    Wick, Wolfgang
    Debus, Juergen
    BMC CANCER, 2010, 10
  • [23] Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
    Kong, Lin
    Gao, Jing
    Hu, Jiyi
    Lu, Rong
    Yang, Jing
    Qiu, Xianxin
    Hu, Weixu
    Lu, Jiade J.
    CANCER COMMUNICATIONS, 2019, 39
  • [24] Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer
    Rödel, C
    Grabenbauer, GG
    Papadopoulos, T
    Hohenberger, W
    Schmoll, HJ
    Sauer, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3098 - 3104
  • [25] Phase I/II trial of carbon-ion radiotherapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer.
    Shinoto, Makoto
    Yamada, Shigeru
    Yasuda, Shigeo
    Imada, Hiroshi
    Shioyama, Yoshiyuki
    Honda, Hiroshi
    Kamada, Tadashi
    Tsujii, Hirohiko
    Saisho, Hiromitsu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] A Phase I clinical trial of carbon ion radiotherapy for Stage I breast cancer: clinical and pathological evaluation
    Karasawa, Kumiko
    Omatsu, Tokuhiki
    Arakawa, Atsushi
    Yamamoto, Naohito
    Ishikawa, Takashi
    Saito, Mitsue
    Fukuda, Shigekazu
    Kamada, Tadashi
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (03) : 342 - 347
  • [27] Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial
    Galanis, E
    Buckner, JC
    Maurer, MJ
    Reid, JM
    Kuffel, MJ
    Ames, MM
    Scheithauer, BW
    Hammack, JE
    Pipoly, G
    Kuross, SA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (05) : 495 - 503
  • [28] Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial
    Evanthia Galanis
    Jan C. Buckner
    Matthew J. Maurer
    Joel M. Reid
    Mary J. Kuffel
    Matthew M. Ames
    Bernd W. Scheithauer
    Julie E. Hammack
    George Pipoly
    Steven A. Kuross
    Investigational New Drugs, 2005, 23 : 495 - 503
  • [29] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [30] Phase I trial of oral topotecan (OT) and radiotherapy (XRT) in rectal cancer (RCA).
    Yeatman, T
    Lima, CMR
    Barthel, J
    Calvin, D
    Garret, C
    Dinwoodie, WR
    Mayfield, S
    Wright, M
    Lush, R
    Sullivan, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S
12345